Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$246M |
| 2 |
ExxonMobil
XOM
|
+$96.1M |
| 3 |
Apple
AAPL
|
+$62M |
| 4 |
Verizon
VZ
|
+$58.6M |
| 5 |
Boeing
BA
|
+$52.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$174M |
| 2 |
SE
Spectra Energy Corp Wi
SE
|
+$85.4M |
| 3 |
STJ
St Jude Medical
STJ
|
+$69M |
| 4 |
Caterpillar
CAT
|
+$63.8M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.76% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 12.7% |
| 4 | Industrials | 11.05% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Scorpio Tankers
STNG
$3.83B
| $1.19M | ﹤0.01% |
26,810
| – | – |
|
|
TTPH
2377
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $1.18M | ﹤0.01% |
6,440
+393
| +6% | +$44.1K |
|
2378
Tejon Ranch
TRC
$445M
| $1.17M | ﹤0.01% |
54,910
+3,170
| +6% | +$71.6K |
|
|
NVTA
2379
DELISTED
Invitae Corporation
NVTA
| $1.16M | ﹤0.01% |
104,994
+22,301
| +27% | +$214K |
|
2380
Calix
CALX
$2.4B
| $1.16M | ﹤0.01% |
159,836
+9,918
| +7% | +$70.2K |
|
2381
Culp Inc
CULP
$42.7M
| $1.16M | ﹤0.01% |
37,063
-16,159
| -30% | -$533K |
|
2382
Akebia Therapeutics
AKBA
$234M
| $1.15M | ﹤0.01% |
125,130
+7,353
| +6% | +$71.8K |
|
|
GOOD
2383
Gladstone Commercial Corp
GOOD
$618M
| $1.15M | ﹤0.01% |
55,400
+11,500
| +26% | +$230K |
|
|
AXAS
2384
DELISTED
Abraxas Petroleum Corp
AXAS
| $1.14M | ﹤0.01% |
28,291
+7,453
| +36% | +$341K |
|
|
TBRG
2385
DELISTED
TruBridge
TBRG
| $1.13M | ﹤0.01% |
40,436
-15,269
| -27% | -$383K |
|
2386
Workiva
WK
$3.66B
| $1.13M | ﹤0.01% |
72,076
+3,762
| +6% | +$52.9K |
|
|
MPG
2387
DELISTED
Metaldyne Performance Group Inc.
MPG
| $1.12M | ﹤0.01% |
49,062
-7,845
| -14% | -$183K |
|
2388
FerroAtlántica
GSM
$865M
| $1.12M | ﹤0.01% |
108,500
| – | – |
|
|
HABT
2389
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $1.12M | ﹤0.01% |
63,182
+20,270
| +47% | +$308K |
|
|
HSKA
2390
DELISTED
Heska Corp
HSKA
| $1.11M | ﹤0.01% |
10,591
-4,622
| -30% | -$395K |
|
2391
Karyopharm Therapeutics
KPTI
$44.4M
| $1.11M | ﹤0.01% |
5,768
+251
| +5% | +$40.3K |
|
2392
Global Indemnity Group
GBLI
$423M
| $1.11M | ﹤0.01% |
28,817
+1,368
| +5% | +$52.5K |
|
|
BBBY
2393
Bed Bath & Beyond
BBBY
$423M
| $1.11M | ﹤0.01% |
85,774
+5,463
| +7% | +$71.2K |
|
2394
Park Aerospace
PKE
$801M
| $1.11M | ﹤0.01% |
62,060
+2,565
| +4% | +$47.8K |
|
2395
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $1.11M | ﹤0.01% |
27,866
-9,354
| -25% | -$361K |
|
|
SFE
2396
DELISTED
Safeguard Scientifics, Inc.
SFE
| $1.1M | ﹤0.01% |
86,757
+5,130
| +6% | +$64.6K |
|
|
GLBL
2397
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
| $1.1M | ﹤0.01% |
229,228
+8,721
| +4% | +$39.4K |
|
2398
Hovnanian Enterprises
HOV
$772M
| $1.09M | ﹤0.01% |
19,283
+4,340
| +29% | +$256K |
|
2399
iRhythm Holdings
IRTC
$4.1B
| $1.09M | ﹤0.01% |
28,981
+8,145
| +39% | +$280K |
|
2400
Yum China
YUMC
$16.5B
| $1.08M | ﹤0.01% |
39,735
+1,778
| +5% | +$47.5K |
|
Similar funds
Charles Schwab's Q1 2017 Portfolio in Review
As of Q1 2017, Charles Schwab held 3,112 positions worth $99.9B, up 9.4% from $91.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.38B of net new capital in Q1 2017, opening 37 new positions and adding to 2,360 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Chevron, an estimated $174M trimmed.
- Charles Schwab's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
- Charles Schwab added most to Home Depot in Q1 2017, an estimated $246M increase.
- Charles Schwab's biggest Q1 2017 reduction was Chevron, cutting an estimated $174M.
- Charles Schwab fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $85.4M.
- Charles Schwab's ten largest holdings make up 14% of its $99.9B portfolio in Q1 2017.
- Charles Schwab opened 37 new positions and closed 57 in Q1 2017.
- Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $99.9B.
Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.